Research Overview
Semax is a synthetic heptapeptide studied in research models involving neuropeptide signaling, cognitive biology, neuroprotection, central nervous system physiology, and neurotrophic factor regulation.
Developed as an analogue of the adrenocorticotropic hormone (ACTH) fragment 4-10, Semax has become an important research peptide for investigating the molecular mechanisms that regulate neuronal communication, synaptic plasticity, and neurobiological adaptation. Its unique pharmacological profile has established it as a valuable tool across neuroscience and cognitive research.
Lyophilized Vial Format
Precision-manufactured and lyophilized for stability, this research-grade peptide is produced to support reproducible laboratory workflows requiring accurate preparation, controlled storage, and consistent experimental performance.
Why Researchers Study Semax
Semax is investigated for its interaction with neuropeptide signaling pathways involved in neuronal function, neurotrophic regulation, and central nervous system communication. Research continues to examine its influence on brain-derived neurotrophic factor (BDNF), neurotransmitter systems, neuronal plasticity, and the molecular mechanisms that coordinate cognitive function and neuroprotection.
Its broad neurobiological profile has made Semax a valuable research peptide for exploring cognitive physiology, neurotrophic signaling, neuronal adaptation, and the complex cellular networks that support central nervous system homeostasis.
Research Applications
Researchers commonly utilize Semax in laboratory investigations involving:
- Neuropeptide signaling
- Neurotrophic factor regulation
- Brain-derived neurotrophic factor (BDNF) research
- Neuroprotection
- Central nervous system physiology
- Cognitive biology
- Neuronal plasticity
- Neurotransmitter signaling
- Learning and memory research
- Experimental neuroscience






